TSX News -
AirBoss Reports 4th Quarter and Full Year 2023 Results
NEWMARKET, Ontario, March 06, 2024 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX: BOS) (OTCQX:ABSSF) (the “Company” or “AirBoss”) today […]
TSX News -
Descartes Announces Fiscal 2024 Fourth Quarter and Annual Financial Results
Record Revenues and Income from Operations WATERLOO, Ontario and ATLANTA, March 06, 2024 (GLOBE NEWSWIRE) — The Descartes Systems Group […]
Paycor Announces Offering of Common Stock by Selling Stockholders
CINCINNATI, March 06, 2024 (GLOBE NEWSWIRE) — Paycor HCM, Inc. (Nasdaq: PYCR) (“Paycor”), a leading provider of human capital management […]
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
TEL AVIV, Israel, March 06, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical […]
Lytus Technologies Enters $326 Billion Data Center Market with Launch of Cutting-Edge Lytus Cloud Infrastructure Services
Dubai, UAE, March 06, 2024 (GLOBE NEWSWIRE) — Lytus Technologies Holdings PTV. Ltd. (the “Company”) (Nasdaq:LYT), a leading global technology-driven […]
MedBright AI Announces Investor Relations Agreement with Anthem Strategies Ltd.
VANCOUVER, British Columbia, March 06, 2024 (GLOBE NEWSWIRE) — MedBright AI Investments Inc. (the “Company” or “MedBright AI”) (CSE:MBAI, OTCQB:MBAIF, […]
Arq to Host Fourth Quarter and Full Year 2023 Conference Call on March 13, 2024
GREENWOOD VILLAGE, Colo., March 06, 2024 (GLOBE NEWSWIRE) — Arq, Inc. (NASDAQ: ARQ) (the “Company” or “Arq”) today announced the […]
Avid Bioservices Announces Proposed Private Placement of Convertible Notes
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization […]
Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) […]
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
Fourth Quarter 2023 Total Revenues of $277 million, which aligned our Full Year to the mid-point of guidance Full Year […]
